G ene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has been challenging. In a study published May 15 in the New England Journal of Medicine and presented at the American Society of Gene and Cell Therapy , researchers led by teams at Children’s Hospital of Philadelphia and University of Pennsylvania report on the first use of the gene-editing technology CRISPR in a customized therapy designed to treat one patient with a rare